Minova Life Science

Minova life sciences - Pharmaceutical company

Transpace-MF Tablet

COMPOSITION – Tranexamic Acid IP 500mg + Mefenamic Acid IP 250mg

Tranexamic Acid

A synthetic cyclohexane derivative, inhibits breakdown of fibrin in blood clots and treats haemorrhage.

Shows better improvement in health-related quality of life compared to ethamsylate in patients with menorrhagia.

Superior to diclofenac in reduction of menstrual blood loss in women with intrauterine contraceptive device-associated menorrhagia.

Mefenamic Acid

Effectively reduces the amount of menstrual blood loss 30-50 % in women with essential menorrhagia.

Relieves pain and abdominal cramps in women with primary dysmenorrhea

Explore other products

Scroll to Top